New Zealand markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.18+0.23 (+2.10%)
At close: 04:00PM EDT
11.08 -0.10 (-0.89%)
After hours: 07:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
283,176
258,215
154,080
80,943
42,220
-
Cost of revenue
171,639
169,273
118,815
79,770
61,291
-
Gross profit
111,537
88,942
35,265
1,173
-19,072
-
Operating expenses
Research development
2,895
3,300
3,614
3,646
5,907
-
Selling general and administrative
60,147
59,020
52,458
42,897
35,051
-
Total operating expenses
67,271
67,310
74,630
59,547
45,843
-
Operating income or loss
44,266
21,632
-39,365
-58,374
-64,915
-
Interest expense
22,681
25,027
19,279
13,057
11,985
-
Total other income/expenses net
-26,469
-26,461
-7,305
-252
863.269
-
Income before tax
-3,049
-28,239
-65,904
-71,648
-75,749
-
Income from continuing operations
-3,644
-28,239
-65,904
-71,648
-75,749
-
Net income
-3,644
-28,239
-65,904
-71,648
-75,749
-
Net income available to common shareholders
-3,644
-28,239
-65,904
-71,648
-75,749
-
Basic EPS
-0.11
-
-0.33
-0.51
-0.88
-0.89
Diluted EPS
-0.11
-
-0.33
-0.51
-0.88
-0.89
Basic average shares
218,201
-
197,875
139,579
86,145
54,348
Diluted average shares
218,201
-
197,875
139,579
86,145
54,348